Bionomics Operating Cash Flow Sales Ratio from 2010 to 2024
| BNOX Stock | USD 0.30 0.02 7.14% |
Operating Cash Flow Sales Ratio | First Reported 2010-12-31 | Previous Quarter (817.40) | Current Value (776.53) | Quarterly Volatility 313.36208621 |
Check Bionomics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bionomics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 412.7 K, Interest Expense of 19 K or Other Operating Expenses of 18.8 B, as well as many indicators such as Price To Sales Ratio of 152.7 K, Dividend Yield of 0.0 or PTB Ratio of 0.56. Bionomics financial statements analysis is a perfect complement when working with Bionomics Valuation or Volatility modules.
Bionomics | Operating Cash Flow Sales Ratio |
Latest Bionomics' Operating Cash Flow Sales Ratio Growth Pattern
Below is the plot of the Operating Cash Flow Sales Ratio of Bionomics Ltd ADR over the last few years. It is Bionomics' Operating Cash Flow Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bionomics' overall financial position and show how it may be relating to other accounts over time.
| Operating Cash Flow Sales Ratio | 10 Years Trend |
|
Operating Cash Flow Sales Ratio |
| Timeline |
Bionomics Operating Cash Flow Sales Ratio Regression Statistics
| Arithmetic Mean | (165.57) | |
| Coefficient Of Variation | (189.26) | |
| Mean Deviation | 241.07 | |
| Median | (1.72) | |
| Standard Deviation | 313.36 | |
| Sample Variance | 98,196 | |
| Range | 817 | |
| R-Value | (0.73) | |
| Mean Square Error | 48,882 | |
| R-Squared | 0.54 | |
| Significance | 0 | |
| Slope | (51.38) | |
| Total Sum of Squares | 1.4M |
Bionomics Operating Cash Flow Sales Ratio History
About Bionomics Financial Statements
Bionomics investors use historical fundamental indicators, such as Bionomics' Operating Cash Flow Sales Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bionomics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Cash Flow Sales Ratio | (817.40) | (776.53) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bionomics Stock Analysis
When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.